|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4900 - 0.5400|
|52 Week Range||0.1250 - 1.2700|
|Beta (3Y Monthly)||-0.60|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
PetVivo Holdings, Inc. (PETV), an emerging biomedical device company, is very pleased to announce that Marble Arch Research Inc., a leading independent equity research provider, has produced a new investment research report on the Company. The updated report provides an overview of recent events, new initiatives, and the company’s valuation relative to its peer group. The sponsored research update also carries a rating and a price target and can be accessed at its partner site, www.GoldmanResearch.com.
Minneapolis, MN, Sept. 11, 2019 -- PetVivo Holdings, Inc. (OTCQB: PETV) Dear Stakeholders of PetVivo Holdings, Inc., PetVivo Holdings, Inc. (OTCQB: PETV) an emerging.
NEW YORK, Aug. 20, 2019 -- FMW Media Corp. announces a partnership with WRNN-TV on Verizon FIOS Channel 6, New York City, New York. The airing of FMW Media’s “New To The.
OTCPINK: PETV PetVivo Holdings, Inc. (www.petvivo.com) announced today the formation of a new nonprofit called PetVivo Cares whose mission is to help extend the lives of services animals. Currently registered as a 371 A organization in the State of Minnesota, PetVivo Cares is in the process of filing its 501c3 status for federal exempt recognition, and anticipates receiving its IRS determination in early 2019. PetVivo Cares will operate as separate entity from PetVivo Holdings Inc. an emerging bio medical company who developed a lameness treatment for horses and dogs called Kush ™.